ArQule Inc

Overview

ArQule Inc (ArQule) is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. It is headquartered in Burlington, Massachusetts, the US.
Key Stats
Address
One Wall Street Burlington United States of America Massachusetts
Headquarters

United States of America

Industry

Pharmaceuticals and Healthcare

Peer Comparison

Key Parameters ArQule Inc
Key Information
Headquarters United States of America
Headquarter City Burlington
Headquarter State/Province Massachusetts
No. of Employees -
Entity Type Private

Products & Services

Employees

History

Year Event Description
2020 Ownership Changes In January, the company was acquired by a subsidiary of Merck Sharp & Dohme.
2018 Regulatory Approval In September, the US FDA granted Fast Track Designation to the company’s pipeline product, miransertib…
2018 Contracts/Agreements In February, ArQule and Roivant Sciences entered into a collaboration to pursue the development of…
2018 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2017 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2017 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
31 Aug 2010 ArQule Inc Enters Phase I/II Clinical Trial Agreement with ICON Plc for tivantinib (GDCT0040892) Contract Service Agreement ArQule Inc; ArQule Inc ICON Plc; ICON Plc
01 Apr 2008 ArQule Inc Enters Phase I Clinical Trial Agreement with Labcorp Drug Development for tivantinib (GDCT0126552) Contract Service Agreement ArQule Inc; ArQule Inc Labcorp Drug Development; Labcorp Drug Development
01 Mar 2008 ArQule Inc Enters Phase I Clinical Trial Agreement with Labcorp Drug Development for tivantinib (GDCT0121774) Contract Service Agreement ArQule Inc; ArQule Inc Labcorp Drug Development; Labcorp Drug Development